Issue of Equity
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA ( OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY ...
Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
TORONTO, April 01, 2025 ( GLOBE NEWSWIRE ) -- Revive Therapeutics Ltd. ( "Revive" or the "Company" ) RVVTF RVV ( FRANKFURT:31R ) , a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and medical countermeasures, is ...
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
CLEVELAND, April 01, 2025 ( GLOBE NEWSWIRE ) -- Abeona Therapeutics Inc. ( Nasdaq: ABEO ) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635 ( c ) ( 4 ) .
Kura Oncology to Participate in Stifel Targeted Oncology Forum
SAN DIEGO, April 01, 2025 ( GLOBE NEWSWIRE ) -- Kura Oncology, Inc. ( NASDAQ: KURA ) , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the Stifel 2025 Virtual Targeted Oncology ...
Ascent Solar Technologies Leadership Offers Thin-Film Solar Facility Tours to Prospective Customers During 40th Annual Space Symposium
THORNTON, Colo., April 01, 2025 ( GLOBE NEWSWIRE ) -- Ascent Solar Technologies ( "Ascent" or the "Company" ) ( Nasdaq: ASTI ) , the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic ( PV ) solutions, today announced that its Director of ...
Cognition Therapeutics Presents Results at AD/PD 2025 Showing Impact of Zervimesine ( CT1812 ) on Alzheimer's Disease Processes
Presentation Shows Pronounced Reduction in Key Plasma Biomarkers Among Prespecified Study Population Presentation Shows Pronounced Reduction in Key Plasma Biomarkers Among Prespecified Study Population ...
Evaxion announces business update and full year 2024 financial results
COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S ( NASDAQ: EVAX ) ( "Evaxion" ) , a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces full year 2024 financial results.
Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.
PRINCETON, N.J., April 01, 2025 ( GLOBE NEWSWIRE ) -- Sonnet BioTherapeutics Holdings, Inc. ( NASDAQ:SONN ) ( the "Company" or "Sonnet" ) , a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment ( TME ) , today announced with deep and profound sadness ...
Watsco Declares $3.00 Quarterly Dividend, Reflects 11% Increase to an Annual Rate of $12.00 Per Share - Watsco ( NYSE:WSO )
MIAMI, April 01, 2025 ( GLOBE NEWSWIRE ) -- Watsco, Inc.'s WSO Board of Directors has declared a regular quarterly cash dividend of $3.00 on each outstanding share of its Common and Class B common stock payable on April 30, 2025 to shareholders of record at the close of business on April 15, ...
ISS Recommends Shareholders Vote "FOR" Amplify's Proposed Acquisition of Assets from Juniper Capital
HOUSTON, April 01, 2025 ( GLOBE NEWSWIRE ) -- Amplify Energy Corp. ( NYSE: AMPY ) ( "Amplify" or the "Company" ) announced that Institutional Shareholder Services ( "ISS" ) , a leading independent proxy advisory firm, has recommended that shareholders vote "FOR" the Company's proposed merger ...
